This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 2358. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016 and in DoD Grant and Agreement Regulations (DoDGARs) 22.315.
The USSOCOM's supporting contracting office, U.S. Army Medical Research Acquisition Activity (USAMRAA) will be the awarding and administering office for proposals/applications selected for funding.
A primary emphasis of the USSOCOM Biomedical, Human Performance, and Canine Research Program is to identify and develop techniques, knowledge products, and materiel (medical devices, drugs, and biologics) for early intervention in life-threatening injuries, prolonged field care (PFC), human performance optimization, canine medicine/performance, brain health, and immune response. Special Operations Forces (SOF) medical personnel place a premium on medical equipment that is small, lightweight, ruggedized, modular, multi-use, and designed for operation in extreme environments. The equipment must be easy to use, require minimum maintenance, and have low power consumption. Drugs and biologics should optimally not require refrigeration or other special handling. All materiel and related techniques must be simple and effective, and easily modified for commercialization. Research projects may apply existing scientific and technical knowledge for which concept and/or patient care efficacy have already been demonstrated to meet SOF requirements.
The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public. Relevant research must be responsive to the health care needs of the Armed Forces, family members of the Armed Forces, the U.S. Veterans and civilian populations. Proposals/applications must address a relevant health problem responsive to one of the Research Areas of Interest (RAI) identified below. Additional RAI's may be added during the life of the BAA (FY18-FY23).
The following RAIs are in no particular order:
Damage Control Resuscitation
- Global Treatment Strategies and Next Generation Wound Management
- Analgesia
- Far Forward Blood, Blood Components, Blood Substitute, & Injectable Hemostatic
- Austere Surgical Stabilization
Prolonged Field Care (PFC)
- Medical Sensors and Devices
Portable Lab Assays and Diagnostics
- Occupational and Environmental Health (OEH) Hazards
- Force Health Protection and Environmental Medicine
- Optimal Acclimatization Strategy
- Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Rapid Diagnostics, Treatment, and Prophylaxis
- Operational Monitoring
Medical Simulation and Training Technologies
- Human Performance Optimization
- Improve Sleep
- Diagnostics for Performance Sustainment
- Nutritional Status
- Enhanced Physiological Performance
- Enhanced Mental Performance
- Optimal Performance Strategy
- Pharmaceutical and Nutritional Supplement interactions
- Wearable Devices
Canine Medicine
- Trauma Resuscitation
- Non-Traditional Anesthesia Protocols
- Optimizing Canine Performance and Nutrition
- Sensory Optimization and Protection
- Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Canine Decontamination, Environmental Extremes
- Brain Health and Traumatic Brain Injury
- Pre and Post Trauma Training / Behavioral Issues
- Canine Simulation Technologies
Brain Health
- Environmental exposures
- Environmental exposure effects
- Biomarkers
- Genetic factors
- Neuropsychological testing
- Olfactory, Oculomotor, auditory, vestibular, cranial nerve, and vocal-acoustic performance
- Postural stability
- Neuroendocrine Dysfunction
- Neuroimaging
- Analytics
- Neuromodulation.
- Brain lymphatics and glymphatics
- Pupillary response and microsacaades
Immune Response